Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The SURMOUNT-1 trial evaluated tirzepatide in adults with obesity or overweight without diabetes
Dual agonist injections with tirzepatide activate both GLP-1 and GIP pathways, providing an additional effect on appetite and glucose control, which may lead to greater weight reduction for some individuals
Calms respiratory symptoms Glutathione produces a byproduct, N-acetylcysteine, which is useful in treating respiratory issues like asthma
Immune System Support Oral and Injection: While glutathiones immune-boosting benefits arent directly tied to skin health, they can help reduce inflammation-related skin issues
Phase 2 clinical trials showed weight loss of up to -24.2% over 48 weeks
References Tian X, Wang L, Zhong L, et al
US$ 25.31
US$ 26.47
US$ 24.43
